Back to search

Article

Real-world genomic landscape of FGFR2 amplifications and fusions in solid tumors: analysis of 4,953 patients using clinical-grade NGS

2026-08-14

Abstract excerpt

Fibroblast growth factor receptor 2 (FGFR2) alterations, including amplifications and fusions, are actionable oncogenic drivers in multiple cancers, but their prevalence and genomic features are not well defined. Between October 2019 and October 2024 at Samsung Medical Center, 4,953 patients with solid tumors underwent next-generation sequencing using TruSight Oncology 500 (TSO 500) assays as part of routine clini...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7efea590-bab5-5125-9a40-a6973781307f
DOI
10.1186/s12885-026-16708-6
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Real-world genomic landscape of FGFR2 amplifications and fusions in solid tumors: analysis of 4,953 patients using clinical-grade NGSDOI 10.1186/s12885-026-16708-6
Select a neighboring publication to make it the new centre.